{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:23Z","timestamp":1792782623879,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangsu Province Geriatric Health Research Project","award":["LKM2022069"],"award-info":[{"award-number":["LKM2022069"]}]},{"name":"Research and Innovation Team Project Contract,The Affiliated Hua\u2019ian No. 1 People's Hospital of Nanjing Medical University","award":["YCT202305"],"award-info":[{"award-number":["YCT202305"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00198-024-07217-y","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T07:02:27Z","timestamp":1723532547000},"page":"2087-2098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Metabolic dysfunction\u2013associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity"],"prefix":"10.1007","volume":"35","author":[{"given":"Jie","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-2711","authenticated-orcid":false,"given":"Juan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"7217_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/s2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K (2022) A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol 10:284\u2013296. https:\/\/doi.org\/10.1016\/s2213-8587(22)00003-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7217_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology (Baltimore, MD) 67:123\u2013133. https:\/\/doi.org\/10.1002\/hep.29466","journal-title":"Hepatology (Baltimore, MD)"},{"key":"7217_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/s2468-1253(22)00317-x","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY et al (2023) Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 8:20\u201330. https:\/\/doi.org\/10.1016\/s2468-1253(22)00317-x","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7217_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/s2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD (2021) Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol 6:578\u2013588. https:\/\/doi.org\/10.1016\/s2468-1253(21)00020-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7217_CR5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158:1999-2014.e1991. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"key":"7217_CR6","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79:1542\u20131556. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"key":"7217_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.maturitas.2021.02.007","volume":"147","author":"SA Polyzos","year":"2021","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Yavropoulou MP, Makras P (2021) Postmenopausal osteoporosis coexisting with other metabolic diseases: treatment considerations. Maturitas 147:19\u201325. https:\/\/doi.org\/10.1016\/j.maturitas.2021.02.007","journal-title":"Maturitas"},{"key":"7217_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467\u2013475. https:\/\/doi.org\/10.1016\/j.bone.2007.11.001","journal-title":"Bone"},{"key":"7217_CR9","doi-asserted-by":"publisher","unstructured":"(2021) Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev 2:e580-e592. https:\/\/doi.org\/10.1016\/s2666-7568(21)00172-0","DOI":"10.1016\/s2666-7568(21)00172-0"},{"key":"7217_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13018-019-1226-6","volume":"14","author":"O Guzon-Illescas","year":"2019","unstructured":"Guzon-Illescas O, Perez Fernandez E, Cresp\u00ed Villarias N, Quir\u00f3s Donate FJ, Pe\u00f1a M, Alonso-Blas C, Garc\u00eda-Vadillo A, Mazzucchelli R (2019) Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res 14:203. https:\/\/doi.org\/10.1186\/s13018-019-1226-6","journal-title":"J Orthop Surg Res"},{"issue":"15","key":"7217_CR11","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.3390\/ijms23158303","volume":"23","author":"A Pi\u00f1ar-Gutierrez","year":"2022","unstructured":"Pi\u00f1ar-Gutierrez A, Garc\u00eda-Fontana C, Garc\u00eda-Fontana B, Mu\u00f1oz-Torres M (2022) Obesity and bone health: a complex relationship. Int J Mol Sci 23(15):8303. https:\/\/doi.org\/10.3390\/ijms23158303","journal-title":"Int J Mol Sci"},{"key":"7217_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3945\/an.117.015545","volume":"8","author":"O Sadeghi","year":"2017","unstructured":"Sadeghi O, Saneei P, Nasiri M, Larijani B, Esmaillzadeh A (2017) Abdominal Obesity and risk of hip fracture: a systematic review and meta-analysis of prospective studies. Adv Nutr (Bethesda, Md) 8:728\u2013738. https:\/\/doi.org\/10.3945\/an.117.015545","journal-title":"Adv Nutr (Bethesda, Md)"},{"key":"7217_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.diabet.2018.10.001","volume":"45","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Sani E, Fassio A et al (2019) Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab 45:347\u2013355. https:\/\/doi.org\/10.1016\/j.diabet.2018.10.001","journal-title":"Diabetes Metab"},{"key":"7217_CR14","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.3350\/cmh.2022.0398","volume":"29","author":"E Ko","year":"2023","unstructured":"Ko E, Yoon EL, Jun DW (2023) Risk factors in nonalcoholic fatty liver disease. Clin Mol Hepatol 29:S79-s85. https:\/\/doi.org\/10.3350\/cmh.2022.0398","journal-title":"Clin Mol Hepatol"},{"key":"7217_CR15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"7217_CR16","doi-asserted-by":"publisher","first-page":"100627","DOI":"10.1016\/j.jhepr.2022.100627","volume":"5","author":"L Crudele","year":"2023","unstructured":"Crudele L, De Matteis C, Piccinin E et al (2023) Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis. JHEP Rep 5:100627. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100627","journal-title":"JHEP Rep"},{"key":"7217_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/pedi.12949","volume":"21","author":"M Medrano","year":"2020","unstructured":"Medrano M, Arenaza L, Ram\u00edrez-V\u00e9lez R, Ortega FB, Ruiz JR, Labayen I (2020) Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight\/obesity: EFIGRO randomized controlled trial. Pediatr Diabetes 21:215\u2013223. https:\/\/doi.org\/10.1111\/pedi.12949","journal-title":"Pediatr Diabetes"},{"key":"7217_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic Steatohepatitis: Rev Jama 323:1175\u20131183. https:\/\/doi.org\/10.1001\/jama.2020.2298","journal-title":"Nonalcoholic Steatohepatitis: Rev Jama"},{"key":"7217_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW (2017) New trends on obesity and NAFLD in Asia. J Hepatol 67:862\u2013873. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.003","journal-title":"J Hepatol"},{"issue":"6","key":"7217_CR20","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/nu13061994","volume":"13","author":"M Mathieu","year":"2021","unstructured":"Mathieu M, Guillot P, Riaudel T, Boureau AS, Chapelet G, Brouessard C, de Decker L, Berrut G (2021) Association between bone mineral density and fat mass independent of lean mass and physical activity in women aged 75 or older. Nutrients 13(6):1994. https:\/\/doi.org\/10.3390\/nu13061994","journal-title":"Nutrients"},{"key":"7217_CR21","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1210\/clinem\/dgad415","volume":"109","author":"R Chen","year":"2024","unstructured":"Chen R, Armamento-Villareal R (2024) Obesity and skeletal fragility. J Clin Endocrinol Metab 109:e466\u2013e477. https:\/\/doi.org\/10.1210\/clinem\/dgad415","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR22","doi-asserted-by":"publisher","first-page":"e13187","DOI":"10.1111\/obr.13187","volume":"22","author":"A Gandham","year":"2021","unstructured":"Gandham A, Mesinovic J, Jansons P, Zengin A, Bonham MP, Ebeling PR, Scott D (2021) Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: a systematic review and meta-analysis. Obes Rev: Off J Int Assoc Study Obes 22:e13187. https:\/\/doi.org\/10.1111\/obr.13187","journal-title":"Obes Rev: Off J Int Assoc Study Obes"},{"key":"7217_CR23","doi-asserted-by":"publisher","first-page":"e0206812","DOI":"10.1371\/journal.pone.0206812","volume":"13","author":"YY Chen","year":"2018","unstructured":"Chen YY, Fang WH, Wang CC, Kao TW, Chang YW, Wu CJ, Zhou YC, Sun YS, Chen WL (2018) Body fat has stronger associations with bone mass density than body mass index in metabolically healthy obesity. PLoS ONE 13:e0206812. https:\/\/doi.org\/10.1371\/journal.pone.0206812","journal-title":"PLoS ONE"},{"key":"7217_CR24","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/dom.14774","volume":"24","author":"ID Vachliotis","year":"2022","unstructured":"Vachliotis ID, Anastasilakis AD, Goulas A, Goulis DG, Polyzos SA (2022) Nonalcoholic fatty liver disease and osteoporosis: a potential association with therapeutic implications. Diabetes Obes Metab 24:1702\u20131720. https:\/\/doi.org\/10.1111\/dom.14774","journal-title":"Diabetes Obes Metab"},{"key":"7217_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00223-016-0229-0","volume":"100","author":"JS Walsh","year":"2017","unstructured":"Walsh JS, Vilaca T (2017) Obesity, type 2 diabetes and bone in adults. Calcif Tissue Int 100:528\u2013535. https:\/\/doi.org\/10.1007\/s00223-016-0229-0","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"7217_CR26","doi-asserted-by":"publisher","first-page":"e000999","DOI":"10.1136\/bmjdrc-2019-000999","volume":"8","author":"X Zhu","year":"2020","unstructured":"Zhu X, Yan H, Chang X, Xia M, Zhang L, Wang L, Sun X, Yang X, Gao X, Bian H (2020) Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation. BMJ Open Diabetes Res Care 8(1):e000999. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000999","journal-title":"BMJ Open Diabetes Res Care"},{"key":"7217_CR27","doi-asserted-by":"publisher","unstructured":"Yu Z, Wu Y, Zhang R, Li Y, Zang S, Liu J (2022) Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes. Endocr Connect 11. https:\/\/doi.org\/10.1530\/ec-22-0174","DOI":"10.1530\/ec-22-0174"},{"key":"7217_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/eje-19-0699","volume":"182","author":"Z Shen","year":"2020","unstructured":"Shen Z, Cen L, Chen X, Pan J, Li Y, Chen W, Yu C (2020) Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study. Eur J Endocrinol 182:157\u2013164. https:\/\/doi.org\/10.1530\/eje-19-0699","journal-title":"Eur J Endocrinol"},{"key":"7217_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12072-022-10461-1","volume":"17","author":"I Barchetta","year":"2023","unstructured":"Barchetta I, Lubrano C, Cimini FA et al (2023) Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease. Hepatol Int 17:357\u2013366. https:\/\/doi.org\/10.1007\/s12072-022-10461-1","journal-title":"Hepatol Int"},{"key":"7217_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00198-023-06687-w","volume":"34","author":"J Liu","year":"2023","unstructured":"Liu J, Tang Y, Feng Z, Chen Y, Zhang X, Xia Y, Geng B (2023) Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017\u20132018. Osteoporos Int 34:713\u2013724. https:\/\/doi.org\/10.1007\/s00198-023-06687-w","journal-title":"Osteoporos Int"},{"key":"7217_CR31","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.clnu.2024.04.034","volume":"43","author":"S Yokoyama","year":"2024","unstructured":"Yokoyama S, Honda T, Ishizu Y et al (2024) Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study at a health examination center. Clin Nutr 43:1425\u20131432. https:\/\/doi.org\/10.1016\/j.clnu.2024.04.034","journal-title":"Clin Nutr"},{"key":"7217_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40618-023-02130-3","volume":"47","author":"J Jadzic","year":"2024","unstructured":"Jadzic J, Milovanovic P, Tomanovic N, Zivkovic V, Djukic D, Nikolic S, Djuric M, Djonic D (2024) Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses. J Endocrinol Invest 47:131\u2013140. https:\/\/doi.org\/10.1007\/s40618-023-02130-3","journal-title":"J Endocrinol Invest"},{"key":"7217_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03724-4","author":"B Pan","year":"2024","unstructured":"Pan B, Zhao Y, Chen C, Cai J, Li K, Wang Y, Liu J (2024) The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD. Endocrine. https:\/\/doi.org\/10.1007\/s12020-024-03724-4","journal-title":"Endocrine"},{"key":"7217_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/oby.23100","volume":"29","author":"BT Li","year":"2021","unstructured":"Li BT, Simon TG, Wang N, Chung RT, Corey KE, Dichtel LE, Samelson EJ, Kiel DP, Long MT (2021) Association between liver fat and bone density is confounded by general and visceral adiposity in a community-based cohort. Obesity (Silver Spring) 29:595\u2013600. https:\/\/doi.org\/10.1002\/oby.23100","journal-title":"Obesity (Silver Spring)"},{"key":"7217_CR35","doi-asserted-by":"publisher","first-page":"891382","DOI":"10.3389\/fendo.2022.891382","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Luo H, Zhang Y, Liu L, Lin R (2022) Association of metabolic dysfunction-associated fatty liver disease and liver stiffness with bone mineral density in American adults. Front Endocrinol (Lausanne) 13:891382. https:\/\/doi.org\/10.3389\/fendo.2022.891382","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7217_CR36","doi-asserted-by":"publisher","first-page":"1278505","DOI":"10.3389\/fendo.2023.1278505","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Li Y, Li S, Zhou J, Wang K, Li Z, Chen N, Chen X (2023) Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia\/osteoporosis in T2DM patients. Front Endocrinol (Lausanne) 14:1278505. https:\/\/doi.org\/10.3389\/fendo.2023.1278505","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7217_CR37","doi-asserted-by":"publisher","first-page":"e0182202","DOI":"10.1371\/journal.pone.0182202","volume":"12","author":"G Kim","year":"2017","unstructured":"Kim G, Kim KJ, Rhee Y, Lim SK (2017) Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS ONE 12:e0182202. https:\/\/doi.org\/10.1371\/journal.pone.0182202","journal-title":"PLoS ONE"},{"key":"7217_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig 127:1\u20134. https:\/\/doi.org\/10.1172\/jci92035","journal-title":"J Clin Investig"},{"key":"7217_CR39","doi-asserted-by":"publisher","first-page":"965258","DOI":"10.3389\/fendo.2022.965258","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gao R, Rong X, Zhu S, Cui Y, Liu H, Li M (2022) Immunoporosis: role of immune system in the pathophysiology of different types of osteoporosis. Front Endocrinol 13:965258. https:\/\/doi.org\/10.3389\/fendo.2022.965258","journal-title":"Front Endocrinol"},{"key":"7217_CR40","doi-asserted-by":"publisher","first-page":"111315","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW (2021) Adipose tissue and insulin resistance in obese. Biomed Pharmacother 137:111315. https:\/\/doi.org\/10.1016\/j.biopha.2021.111315","journal-title":"Biomed Pharmacother"},{"key":"7217_CR41","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610\u2013614. https:\/\/doi.org\/10.1038\/39335","journal-title":"Nature"},{"key":"7217_CR42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","volume":"3","author":"JK Sethi","year":"2021","unstructured":"Sethi JK, Hotamisligil GS (2021) Metabolic messengers: tumour necrosis factor. Nat Metab 3:1302\u20131312. https:\/\/doi.org\/10.1038\/s42255-021-00470-z","journal-title":"Nat Metab"},{"key":"7217_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cld.2004.04.006","volume":"8","author":"J Choudhury","year":"2004","unstructured":"Choudhury J, Sanyal AJ (2004) Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 8:575\u2013594. https:\/\/doi.org\/10.1016\/j.cld.2004.04.006","journal-title":"Clin Liver Dis"},{"key":"7217_CR44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cell.2022.01.016","volume":"185","author":"K Fulzele","year":"2022","unstructured":"Fulzele K, Riddle RC, DiGirolamo DJ et al (2022) Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 185:746. https:\/\/doi.org\/10.1016\/j.cell.2022.01.016","journal-title":"Cell"},{"key":"7217_CR45","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/circresaha.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM (2020) Metabolic inflammation and insulin resistance in obesity. Circ Res 126:1549\u20131564. https:\/\/doi.org\/10.1161\/circresaha.119.315896","journal-title":"Circ Res"},{"key":"7217_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.346312.120","volume":"35","author":"YS Lee","year":"2021","unstructured":"Lee YS, Olefsky J (2021) Chronic tissue inflammation and metabolic disease. Genes Dev 35:307\u2013328. https:\/\/doi.org\/10.1101\/gad.346312.120","journal-title":"Genes Dev"},{"key":"7217_CR47","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jc.2013-3338","volume":"99","author":"D Shin","year":"2014","unstructured":"Shin D, Kim S, Kim KH, Lee K, Park SM (2014) Association between insulin resistance and bone mass in men. J Clin Endocrinol Metab 99:988\u2013995. https:\/\/doi.org\/10.1210\/jc.2013-3338","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR48","doi-asserted-by":"publisher","first-page":"8796","DOI":"10.1038\/s41598-023-32931-8","volume":"13","author":"P Gu","year":"2023","unstructured":"Gu P, Pu B, Xin Q et al (2023) The metabolic score of insulin resistance is positively correlated with bone mineral density in postmenopausal patients with type 2 diabetes mellitus. Sci Rep 13:8796. https:\/\/doi.org\/10.1038\/s41598-023-32931-8","journal-title":"Sci Rep"},{"key":"7217_CR49","doi-asserted-by":"publisher","first-page":"e0296935","DOI":"10.1371\/journal.pone.0296935","volume":"19","author":"X Xuan","year":"2024","unstructured":"Xuan X, Sun R, Peng C, Liu L, Huang T, Huang C (2024) The nonlinear association between triglyceride glucose-body mass index and femoral neck BMD in nondiabetic elderly men: NHANES 2005-March 2020. PLoS ONE 19:e0296935. https:\/\/doi.org\/10.1371\/journal.pone.0296935","journal-title":"PLoS ONE"},{"key":"7217_CR50","doi-asserted-by":"publisher","first-page":"840361","DOI":"10.3389\/fendo.2022.840361","volume":"13","author":"A Bhangoo","year":"2022","unstructured":"Bhangoo A, Gupta R, Shelov SP et al (2022) Fasting serum IGFBP-1 as a marker of insulin resistance in diverse school age groups. Front Endocrinol 13:840361. https:\/\/doi.org\/10.3389\/fendo.2022.840361","journal-title":"Front Endocrinol"},{"key":"7217_CR51","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1210\/clinem\/dgad491","volume":"109","author":"MC Okawa","year":"2023","unstructured":"Okawa MC, Tuska RM, Lightbourne M, Abel BS, Walter M, Dai Y, Cochran E, Brown RJ (2023) Insulin signaling through the insulin receptor increases linear growth through effects on bone and the GH-IGF-1 axis. J Clin Endocrinol Metab 109:e96\u2013e106. https:\/\/doi.org\/10.1210\/clinem\/dgad491","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR52","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1210\/jc.2016-3609","volume":"102","author":"C Verroken","year":"2017","unstructured":"Verroken C, Zmierczak HG, Goemaere S, Kaufman JM, Lapauw B (2017) Insulin resistance is associated with smaller cortical bone size in nondiabetic men at the age of peak bone mass. J Clin Endocrinol Metab 102:1807\u20131815. https:\/\/doi.org\/10.1210\/jc.2016-3609","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR53","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2016-1726","volume":"101","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue VV, Finkelstein JS, Bouxsein ML, Yu EW (2016) Association between insulin resistance and bone structure in nondiabetic postmenopausal women. J Clin Endocrinol Metab 101:3114\u20133122. https:\/\/doi.org\/10.1210\/jc.2016-1726","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR54","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1074\/jbc.M308351200","volume":"279","author":"Q Cao","year":"2004","unstructured":"Cao Q, Mak KM, Ren C, Lieber CS (2004) Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK\/STAT and JAK-mediated H2O2-dependant MAPK pathways. J Biol Chem 279:4292\u20134304. https:\/\/doi.org\/10.1074\/jbc.M308351200","journal-title":"J Biol Chem"},{"key":"7217_CR55","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hep.20965","volume":"42","author":"S Aleffi","year":"2005","unstructured":"Aleffi S, Petrai I, Bertolani C et al (2005) Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology (Baltimore, MD) 42:1339\u20131348. https:\/\/doi.org\/10.1002\/hep.20965","journal-title":"Hepatology (Baltimore, MD)"},{"key":"7217_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tem.2015.01.002","volume":"26","author":"NK Saxena","year":"2015","unstructured":"Saxena NK, Anania FA (2015) Adipocytokines and hepatic fibrosis. Trends Endocrinol Metab 26:153\u2013161. https:\/\/doi.org\/10.1016\/j.tem.2015.01.002","journal-title":"Trends Endocrinol Metab"},{"key":"7217_CR57","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.7150\/thno.85369","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang L, Ma Y et al (2023) Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma. Theranostics 13:4430\u20134448. https:\/\/doi.org\/10.7150\/thno.85369","journal-title":"Theranostics"},{"key":"7217_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12935-020-01641-w","volume":"21","author":"H Huang","year":"2021","unstructured":"Huang H, Zhang J, Ling F et al (2021) Leptin receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7. Cancer Cell Int 21:4. https:\/\/doi.org\/10.1186\/s12935-020-01641-w","journal-title":"Cancer Cell Int"},{"key":"7217_CR59","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2022.04.010","volume":"34","author":"G Karsenty","year":"2022","unstructured":"Karsenty G, Khosla S (2022) The crosstalk between bone remodeling and energy metabolism: a translational perspective. Cell Metab 34:805\u2013817. https:\/\/doi.org\/10.1016\/j.cmet.2022.04.010","journal-title":"Cell Metab"},{"key":"7217_CR60","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2337\/db20-1073","volume":"70","author":"J Ryu","year":"2021","unstructured":"Ryu J, Hadley JT, Li Z et al (2021) Adiponectin alleviates diet-induced inflammation in the liver by suppressing MCP-1 expression and macrophage infiltration. Diabetes 70:1303\u20131316. https:\/\/doi.org\/10.2337\/db20-1073","journal-title":"Diabetes"},{"issue":"8","key":"7217_CR61","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/ijms18081649","volume":"18","author":"TE Adolph","year":"2017","unstructured":"Adolph TE, Grander C, Grabherr F, Tilg H (2017) Adipokines and non-alcoholic fatty liver disease: multiple interactions. Int J Mol Sci 18(8):1649. https:\/\/doi.org\/10.3390\/ijms18081649","journal-title":"Int J Mol Sci"},{"key":"7217_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11154-019-09510-2","volume":"20","author":"SM Ishtiaq","year":"2019","unstructured":"Ishtiaq SM, Rashid H, Hussain Z, Arshad MI, Khan JA (2019) Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease. Rev Endocr Metab Disord 20:253\u2013261. https:\/\/doi.org\/10.1007\/s11154-019-09510-2","journal-title":"Rev Endocr Metab Disord"},{"issue":"21","key":"7217_CR63","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/cancers15215306","volume":"15","author":"ID Vachliotis","year":"2023","unstructured":"Vachliotis ID, Valsamidis I, Polyzos SA (2023) Tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Cancers 15(21):5306. https:\/\/doi.org\/10.3390\/cancers15215306","journal-title":"Cancers"},{"key":"7217_CR64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00223-016-0216-5","volume":"100","author":"D Naot","year":"2017","unstructured":"Naot D, Musson DS, Cornish J (2017) The activity of adiponectin in bone. Calcif Tissue Int 100:486\u2013499. https:\/\/doi.org\/10.1007\/s00223-016-0216-5","journal-title":"Calcif Tissue Int"},{"key":"7217_CR65","doi-asserted-by":"publisher","first-page":"155694","DOI":"10.1016\/j.metabol.2023.155694","volume":"148","author":"L Valenzuela-Vallejo","year":"2023","unstructured":"Valenzuela-Vallejo L, Chrysafi P, Kouvari M et al (2023) Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: a multicenter observational study. Metab: Clin Exp 148:155694. https:\/\/doi.org\/10.1016\/j.metabol.2023.155694","journal-title":"Metab: Clin Exp"},{"key":"7217_CR66","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s42000-022-00387-6","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Zusi C, Csermely A, Salvagno GL, Colecchia A, Lippi G, Maffeis C, Targher G (2022) Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study. Hormones (Athens) 21:477\u2013486. https:\/\/doi.org\/10.1007\/s42000-022-00387-6","journal-title":"Hormones (Athens)"},{"key":"7217_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-020-00122-0","volume":"9","author":"JW Lewis","year":"2021","unstructured":"Lewis JW, Edwards JR, Naylor AJ, McGettrick HM (2021) Adiponectin signalling in bone homeostasis, with age and in disease. Bone research 9:1. https:\/\/doi.org\/10.1038\/s41413-020-00122-0","journal-title":"Bone research"},{"key":"7217_CR68","doi-asserted-by":"publisher","first-page":"762335","DOI":"10.3389\/fcell.2021.762335","volume":"9","author":"Y Gong","year":"2021","unstructured":"Gong Y, Wang Y, Zhang Y, Wang L, Wan L, Zu Y, Li C, Wang X, Cui ZK (2021) Paracrine effects of recombinant human adiponectin promote bone regeneration. Front Cell Dev Biol 9:762335. https:\/\/doi.org\/10.3389\/fcell.2021.762335","journal-title":"Front Cell Dev Biol"},{"key":"7217_CR69","doi-asserted-by":"publisher","first-page":"873699","DOI":"10.3389\/fendo.2022.873699","volume":"13","author":"Y Ren","year":"2022","unstructured":"Ren Y, Zhao H, Yin C, Lan X, Wu L, Du X, Griffiths HR, Gao D (2022) Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation. Front Endocrinol 13:873699. https:\/\/doi.org\/10.3389\/fendo.2022.873699","journal-title":"Front Endocrinol"},{"key":"7217_CR70","doi-asserted-by":"publisher","first-page":"E1418","DOI":"10.1152\/ajpendo.00048.2014","volume":"306","author":"Y Wu","year":"2014","unstructured":"Wu Y, Tu Q, Valverde P et al (2014) Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am J Physiol Endocrinol Metab 306:E1418-1430. https:\/\/doi.org\/10.1152\/ajpendo.00048.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7217_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00774-013-0511-4","volume":"32","author":"J Mohiti-Ardekani","year":"2014","unstructured":"Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia MB, Mohiti A (2014) Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J Bone Miner Metab 32:400\u2013404. https:\/\/doi.org\/10.1007\/s00774-013-0511-4","journal-title":"J Bone Miner Metab"},{"key":"7217_CR72","doi-asserted-by":"publisher","first-page":"1044039","DOI":"10.3389\/fendo.2023.1044039","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee S, Kim JH, Jeon YK, Lee JS, Kim K, Hwang SK, Kim JH, Goh TS, Kim YH (2023) Effect of adipokine and ghrelin levels on BMD and fracture risk: an updated systematic review and meta-analysis. Front Endocrinol 14:1044039. https:\/\/doi.org\/10.3389\/fendo.2023.1044039","journal-title":"Front Endocrinol"},{"key":"7217_CR73","doi-asserted-by":"publisher","first-page":"116266","DOI":"10.1016\/j.bone.2021.116266","volume":"155","author":"B He","year":"2022","unstructured":"He B, Zhao J, Zhang M, Yin L, Quan Z, Ou Y, Huang W (2022) Causal roles of circulating adiponectin in osteoporosis and cancers. Bone 155:116266. https:\/\/doi.org\/10.1016\/j.bone.2021.116266","journal-title":"Bone"},{"key":"7217_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","volume":"20","author":"H Tilg","year":"2020","unstructured":"Tilg H, Zmora N, Adolph TE, Elinav E (2020) The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 20:40\u201354. https:\/\/doi.org\/10.1038\/s41577-019-0198-4","journal-title":"Nat Rev Immunol"},{"key":"7217_CR75","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","volume":"68","author":"T Jensen","year":"2018","unstructured":"Jensen T, Abdelmalek MF, Sullivan S et al (2018) Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol 68:1063\u20131075. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.019","journal-title":"J Hepatol"},{"key":"7217_CR76","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M (2022) Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab 34:1700\u20131718. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.017","journal-title":"Cell Metab"},{"key":"7217_CR77","doi-asserted-by":"publisher","first-page":"1025706","DOI":"10.3389\/fendo.2022.1025706","volume":"13","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Zhang L, Yang L, Chu H (2022) The critical role of gut microbiota in obesity. Front Endocrinol 13:1025706. https:\/\/doi.org\/10.3389\/fendo.2022.1025706","journal-title":"Front Endocrinol"},{"key":"7217_CR78","doi-asserted-by":"publisher","first-page":"108622","DOI":"10.1016\/j.jnutbio.2021.108622","volume":"92","author":"RE Moreira J\u00fanior","year":"2021","unstructured":"Moreira J\u00fanior RE, de Carvalho LM, Dos Reis DC, Cassali GD, Faria AMC, Maioli TU, Brunialti-Godard AL (2021) Diet-induced obesity leads to alterations in behavior and gut microbiota composition in mice. J Nutr Biochem 92:108622. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108622","journal-title":"J Nutr Biochem"},{"key":"7217_CR79","doi-asserted-by":"publisher","first-page":"e2100950","DOI":"10.1002\/mnfr.202100950","volume":"66","author":"KP Li","year":"2022","unstructured":"Li KP, Yuan M, Wu YL, Pineda M, Zhang CM, Chen YF, Chen ZQ, Rong XL, Turnbull JE, Guo J (2022) A high-fat high-fructose diet dysregulates the homeostatic crosstalk between gut microbiome, metabolome, and immunity in an experimental model of obesity. Mol Nutr Food Res 66:e2100950. https:\/\/doi.org\/10.1002\/mnfr.202100950","journal-title":"Mol Nutr Food Res"},{"key":"7217_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","volume":"12","author":"J Behary","year":"2021","unstructured":"Behary J, Amorim N, Jiang XT et al (2021) Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun 12:187. https:\/\/doi.org\/10.1038\/s41467-020-20422-7","journal-title":"Nat Commun"},{"key":"7217_CR81","doi-asserted-by":"publisher","first-page":"e3450","DOI":"10.7717\/peerj.3450","volume":"5","author":"J Wang","year":"2017","unstructured":"Wang J, Wang Y, Gao W, Wang B, Zhao H, Zeng Y, Ji Y, Hao D (2017) Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. PeerJ 5:e3450. https:\/\/doi.org\/10.7717\/peerj.3450","journal-title":"PeerJ"},{"key":"7217_CR82","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/rheumatology\/kez302","volume":"58","author":"M Das","year":"2019","unstructured":"Das M, Cronin O, Keohane DM et al (2019) Gut microbiota alterations associated with reduced bone mineral density in older adults. Rheumatology (Oxford) 58:2295\u20132304. https:\/\/doi.org\/10.1093\/rheumatology\/kez302","journal-title":"Rheumatology (Oxford)"},{"key":"7217_CR83","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00198-019-04855-5","volume":"30","author":"C Li","year":"2019","unstructured":"Li C, Huang Q, Yang R, Dai Y, Zeng Y, Tao L, Li X, Zeng J, Wang Q (2019) Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China. Osteoporos Int 30:1003\u20131013. https:\/\/doi.org\/10.1007\/s00198-019-04855-5","journal-title":"Osteoporos Int"},{"key":"7217_CR84","doi-asserted-by":"publisher","first-page":"8583","DOI":"10.18632\/aging.103168","volume":"12","author":"J He","year":"2020","unstructured":"He J, Xu S, Zhang B et al (2020) Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging (Albany NY) 12:8583\u20138604. https:\/\/doi.org\/10.18632\/aging.103168","journal-title":"Aging (Albany NY)"},{"key":"7217_CR85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature10213","volume":"474","author":"AL Kau","year":"2011","unstructured":"Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human nutrition, the gut microbiome and the immune system. Nature 474:327\u2013336. https:\/\/doi.org\/10.1038\/nature10213","journal-title":"Nature"},{"issue":"17","key":"7217_CR86","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.3390\/ijms22179452","volume":"22","author":"KD Seely","year":"2021","unstructured":"Seely KD, Kotelko CA, Douglas H, Bealer B, Brooks AE (2021) The human gut microbiota: a key mediator of osteoporosis and osteogenesis. Int J Mol Sci 22(17):9452. https:\/\/doi.org\/10.3390\/ijms22179452","journal-title":"Int J Mol Sci"},{"key":"7217_CR87","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/jbmr.1588","volume":"27","author":"K Sj\u00f6gren","year":"2012","unstructured":"Sj\u00f6gren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, B\u00e4ckhed F, Ohlsson C (2012) The gut microbiota regulates bone mass in mice. J Bone Miner Res 27:1357\u20131367. https:\/\/doi.org\/10.1002\/jbmr.1588","journal-title":"J Bone Miner Res"},{"key":"7217_CR88","doi-asserted-by":"publisher","first-page":"3686749","DOI":"10.1155\/2020\/3686749","volume":"2020","author":"P Locantore","year":"2020","unstructured":"Locantore P, Del Gatto V, Gelli S, Paragliola RM, Pontecorvi A (2020) The interplay between immune system and microbiota in osteoporosis. Mediators Inflamm 2020:3686749. https:\/\/doi.org\/10.1155\/2020\/3686749","journal-title":"Mediators Inflamm"},{"key":"7217_CR89","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/gut.2003.024505","volume":"54","author":"S Sanz","year":"2005","unstructured":"Sanz S, Pucilowska JB, Liu S et al (2005) Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 54:134\u2013141. https:\/\/doi.org\/10.1136\/gut.2003.024505","journal-title":"Gut"},{"key":"7217_CR90","doi-asserted-by":"publisher","first-page":"34605","DOI":"10.1038\/srep34605","volume":"6","author":"H Nishizawa","year":"2016","unstructured":"Nishizawa H, Iguchi G, Fukuoka H et al (2016) IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci Rep 6:34605. https:\/\/doi.org\/10.1038\/srep34605","journal-title":"Sci Rep"},{"key":"7217_CR91","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbrc.2012.05.115","volume":"423","author":"H Nishizawa","year":"2012","unstructured":"Nishizawa H, Takahashi M, Fukuoka H, Iguchi G, Kitazawa R, Takahashi Y (2012) GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. Biochem Biophys Res Commun 423:295\u2013300. https:\/\/doi.org\/10.1016\/j.bbrc.2012.05.115","journal-title":"Biochem Biophys Res Commun"},{"key":"7217_CR92","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0006-291x(88)90570-0","volume":"151","author":"M Ernst","year":"1988","unstructured":"Ernst M, Froesch ER (1988) Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Commun 151:142\u2013147. https:\/\/doi.org\/10.1016\/0006-291x(88)90570-0","journal-title":"Biochem Biophys Res Commun"},{"key":"7217_CR93","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endo-122-1-254","volume":"122","author":"JM Hock","year":"1988","unstructured":"Hock JM, Centrella M, Canalis E (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254\u2013260. https:\/\/doi.org\/10.1210\/endo-122-1-254","journal-title":"Endocrinology"},{"key":"7217_CR94","doi-asserted-by":"publisher","first-page":"e3624","DOI":"10.1210\/clinem\/dgac405","volume":"107","author":"LE Dichtel","year":"2022","unstructured":"Dichtel LE, Corey KE, Haines MS et al (2022) The GH\/IGF-1 axis is associated with intrahepatic lipid content and hepatocellular damage in overweight\/obesity. J Clin Endocrinol Metab 107:e3624\u2013e3632. https:\/\/doi.org\/10.1210\/clinem\/dgac405","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR95","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/db15-0370","volume":"64","author":"J Cordoba-Chacon","year":"2015","unstructured":"Cordoba-Chacon J, Majumdar N, List EO, Diaz-Ruiz A, Frank SJ, Manzano A, Bartrons R, Puchowicz M, Kopchick JJ, Kineman RD (2015) Growth hormone inhibits hepatic de novo lipogenesis in adult mice. Diabetes 64:3093\u20133103. https:\/\/doi.org\/10.2337\/db15-0370","journal-title":"Diabetes"},{"key":"7217_CR96","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.2337\/db16-0649","volume":"65","author":"Z Liu","year":"2016","unstructured":"Liu Z, Cordoba-Chacon J, Kineman RD, Cronstein BN, Muzumdar R, Gong Z, Werner H, Yakar S (2016) Growth hormone control of hepatic lipid metabolism. Diabetes 65:3598\u20133609. https:\/\/doi.org\/10.2337\/db16-0649","journal-title":"Diabetes"},{"key":"7217_CR97","doi-asserted-by":"publisher","first-page":"T139","DOI":"10.1530\/jme-18-0016","volume":"61","author":"DR Clemmons","year":"2018","unstructured":"Clemmons DR (2018) Role of IGF-binding proteins in regulating IGF responses to changes in metabolism. J Mol Endocrinol 61:T139-t169. https:\/\/doi.org\/10.1530\/jme-18-0016","journal-title":"J Mol Endocrinol"},{"key":"7217_CR98","doi-asserted-by":"publisher","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"Stanley TL, Fourman LT, Zheng I et al (2021) Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 106:e520\u2013e533. https:\/\/doi.org\/10.1210\/clinem\/dgaa792","journal-title":"J Clin Endocrinol Metab"},{"key":"7217_CR99","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1113\/ep088351","volume":"105","author":"SY Lee","year":"2020","unstructured":"Lee SY, Fam KD, Chia KL, Yap MMC, Goh J, Yeo KP, Yap EPH, Chotirmall SH, Lim CL (2020) Age-related bone loss is associated with FGF21 but not IGFBP1 in healthy adults. Exp Physiol 105:622\u2013631. https:\/\/doi.org\/10.1113\/ep088351","journal-title":"Exp Physiol"},{"key":"7217_CR100","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi TH, Scialdone A, Graja A et al (2017) Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell 20:771-784.e776. https:\/\/doi.org\/10.1016\/j.stem.2017.02.009","journal-title":"Cell Stem Cell"},{"key":"7217_CR101","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bone.2018.03.012","volume":"119","author":"CP Hawkes","year":"2019","unstructured":"Hawkes CP, Mostoufi-Moab S (2019) Fat-bone interaction within the bone marrow milieu: impact on hematopoiesis and systemic energy metabolism. Bone 119:57\u201364. https:\/\/doi.org\/10.1016\/j.bone.2018.03.012","journal-title":"Bone"},{"key":"7217_CR102","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/jbmr.3408","volume":"33","author":"M Tencerova","year":"2018","unstructured":"Tencerova M, Figeac F, Ditzel N, Taipaleenm\u00e4ki H, Nielsen TK, Kassem M (2018) High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice. J Bone Min Res: Off J Am Soc Bone Min Res 33:1154\u20131165. https:\/\/doi.org\/10.1002\/jbmr.3408","journal-title":"J Bone Min Res: Off J Am Soc Bone Min Res"},{"key":"7217_CR103","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/oby.2010.106","volume":"19","author":"MA Bredella","year":"2011","unstructured":"Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Rosen CJ, Klibanski A, Miller KK (2011) Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring, Md) 19:49\u201353. https:\/\/doi.org\/10.1038\/oby.2010.106","journal-title":"Obesity (Silver Spring, Md)"},{"key":"7217_CR104","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/jbmr.4504","volume":"37","author":"GN Woods","year":"2022","unstructured":"Woods GN, Ewing SK, Schafer AL et al (2022) Saturated and unsaturated bone marrow lipids have distinct effects on bone density and fracture risk in older adults. J Bone Min Res: Off J Am Soc Bone Min Res 37:700\u2013710. https:\/\/doi.org\/10.1002\/jbmr.4504","journal-title":"J Bone Min Res: Off J Am Soc Bone Min Res"},{"key":"7217_CR105","doi-asserted-by":"publisher","first-page":"115103","DOI":"10.1016\/j.bone.2019.115103","volume":"129","author":"V Singhal","year":"2019","unstructured":"Singhal V, Bose A, Liang Y, Srivastava G, Goode S, Stanford FC, Misra M, Bredella MA (2019) Marrow adipose tissue in adolescent girls with obesity. Bone 129:115103. https:\/\/doi.org\/10.1016\/j.bone.2019.115103","journal-title":"Bone"},{"key":"7217_CR106","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/a:1011513223894","volume":"2","author":"J Justesen","year":"2001","unstructured":"Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165\u2013171. https:\/\/doi.org\/10.1023\/a:1011513223894","journal-title":"Biogerontology"},{"key":"7217_CR107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cytogfr.2020.02.003","volume":"52","author":"J Li","year":"2020","unstructured":"Li J, Chen X, Lu L, Yu X (2020) The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis. Cytokine Growth Factor Rev 52:88\u201398. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.02.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"7217_CR108","doi-asserted-by":"publisher","first-page":"e52481","DOI":"10.15252\/embr.202152481","volume":"22","author":"Y Hu","year":"2021","unstructured":"Hu Y, Li X, Zhi X et al (2021) RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO reports 22:e52481. https:\/\/doi.org\/10.15252\/embr.202152481","journal-title":"EMBO reports"},{"key":"7217_CR109","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jbmr.4229","volume":"36","author":"CS Rajapakse","year":"2021","unstructured":"Rajapakse CS, Johncola AJ, Batzdorf AS, Jones BC, Al Mukaddam M, Sexton K, Shults J, Leonard MB, Snyder PJ, Wehrli FW (2021) Effect of low-intensity vibration on bone strength, microstructure, and adiposity in pre-osteoporotic postmenopausal women: a randomized placebo-controlled trial. J Bone Min Res: Off J Am Soc Bone Min Res 36:673\u2013684. https:\/\/doi.org\/10.1002\/jbmr.4229","journal-title":"J Bone Min Res: Off J Am Soc Bone Min Res"},{"key":"7217_CR110","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3892\/ijmm.2017.3280","volume":"41","author":"Q Liu","year":"2018","unstructured":"Liu Q, Zhang X, Jiao Y et al (2018) In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats. Int J Mol Med 41:669\u2013678. https:\/\/doi.org\/10.3892\/ijmm.2017.3280","journal-title":"Int J Mol Med"},{"key":"7217_CR111","doi-asserted-by":"publisher","first-page":"425.e429","DOI":"10.1016\/j.crad.2016.11.017","volume":"72","author":"NY Yu","year":"2017","unstructured":"Yu NY, Wolfson T, Middleton MS, Hamilton G, Gamst A, Angeles JE, Schwimmer JB, Sirlin CB (2017) Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. Clin Radiol 72:425.e429-425.e414. https:\/\/doi.org\/10.1016\/j.crad.2016.11.017","journal-title":"Clin Radiol"},{"key":"7217_CR112","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1210\/clinem\/dgad429","volume":"109","author":"I Labayen","year":"2023","unstructured":"Labayen I, Cadenas-S\u00e1nchez C, Idoate F, Medrano M, Tobalina I, Villanueva A, Rodr\u00edguez-Vigil B, \u00c1lvarez de Eulate N, Os\u00e9s M, Cabeza R (2023) Liver fat, bone marrow adipose tissue, and bone mineral density in children with overweight. J Clin Endocrinol Metab 109:e253\u2013e258. https:\/\/doi.org\/10.1210\/clinem\/dgad429","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07217-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07217-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07217-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:42:01Z","timestamp":1732077721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07217-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":112,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["7217"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07217-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}